New ‘DNA Organizer’ Offers Hope for Infertility and Cancer Treatment
Table of Contents
A research team at Kyoto University has discovered STAG3-cohesin, a new mitotic cohesin complex crucial for establishing the unique DNA architecture of spermatogonial stem cells (SSCs) – the stem cells responsible for sperm production. This discovery, published in Nature Structural & Molecular biology on August 25, 2025, reveals a critical component in the process of sperm advancement and offers potential new avenues for treating both infertility and certain cancers.
Without STAG3, sscs in mice cannot differentiate properly, leading to fertility issues. Importantly, researchers also found that STAG3 is highly expressed in human immune B cells and B-cell lymphomas. Blocking STAG3 slowed the growth of these cancerous cells, suggesting a potential therapeutic target.
This research is led by Prof. Mitinori Saitou, Director/Principal Investigator at the Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Dr. Masahiro Nagano, and Dr.Bo Hu.
Understanding DNA institution and Cohesins
Our bodies contain the same DNA in every cell, but what makes each cell type unique is how that DNA is organized. Imagine two meters of DNA string needing to fit inside a space smaller than a human hair. This requires precise folding and organization, with boundaries that control gene activity. Ring-shaped protein complexes called cohesins are key to creating these boundaries.
Previously, cohesin complexes were thought to exist primarily in two forms: mitotic cohesins (containing STAG1 or STAG2 with RAD21) and meiotic cohesins. This new research identifies a third distinct form – STAG3-cohesin – with a specialized role in spermatogonial stem cells.
Key Takeaways
- STAG3-cohesin is essential for proper sperm development in mice. Its absence leads to impaired differentiation of spermatogonial stem cells and subsequent infertility.
- STAG3 is highly expressed in human B cells and B-cell lymphomas. This suggests a link between DNA organization and these immune cells and cancers.
- Blocking STAG3 slows the growth of B-cell lymphomas. This indicates a potential therapeutic strategy for treating this type of cancer.
- This discovery expands our understanding of cohesin complexes. It identifies a previously unknown form – STAG3-cohesin – with a specific function.
Frequently Asked Questions (FAQ)
What are spermatogonial stem cells (sscs)?
SSCs are the stem cells that produce sperm. They have the unique ability to self-renew and differentiate into mature sperm cells.
What is a cohesin complex?
Cohesin complexes are ring-shaped protein structures that play a vital role in organizing DNA within the cell nucleus. They help create boundaries that regulate gene expression.
How could this research lead to new cancer treatments?
Because STAG3 is highly expressed in B-cell lymphomas and blocking it slows their growth, it represents a potential target for new drugs designed to disrupt cancer cell proliferation.
Looking Ahead
This discovery opens exciting new avenues for research.Future studies will focus on fully understanding the mechanisms by which STAG3-cohesin regulates DNA organization in SSCs and B cells. Researchers will also investigate the potential of targeting STAG3 as a therapeutic strategy for infertility and B-cell lymphomas.The identification of this new cohesin complex represents a notable step forward in our understanding of genome organization and its impact on both reproductive health and disease.
Publication Date: 2025/08/27 05:01:57